Asia Pacific drug discovery market will grow by 10.6% annually with a total addressable market cap of $231.8 billion over 2021-2030 owing the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration of patents.
Highlighted with 33 tables and 63 figures, this 120-page report “Asia Pacific Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific drug discovery market in every aspect of the classification from perspectives of Drug Type, Service, Process, Technology, Therapeutic Area, End User, and Country.
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Drug Type, Service, and Therapeutic Area over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Five Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific drug discovery market in every aspect of the classification from perspectives of Drug Type, Service, Process, Technology, Therapeutic Area, End User, and Country.
Based on Drug Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
- Small Molecule Drugs
- Biologic Drugs
Based on Service, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
- Medicinal Chemical Services
- Biological Services
- Drug Metabolism and Pharmacokinetics (DMPK) Services
- Other Pharmaceutical Services
Based on Process, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
- Target Selection
- Target Validation
- Hit-To-Lead Identification
- Lead Optimization
- Candidate Validation
Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
- High Throughput Screening
- Combinatorial Chemistry
- Pharmacogenomics and Pharmacogenetics
- Nanotechnology
- Bioanalytical Instruments
- Biochips
- Bioinformatics
- Other Technologies
Based on Therapeutic Area, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
- Oncology
- Neurology
- Infectious and Immune System Diseases
- Digestive System Diseases
- Cardiovascular Diseases
- Diabetes
- Respiratory Disease
- Other Therapeutic Areas
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
- Pharmaceutical Companies
- Contract Research Organizations (CROs)
- Research Institutes
- Other End Users
Geographically, the following national/local markets are fully investigated:
- Japan
- China
- South Korea
- Australia
- India
- Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Drug Type, Service, and Therapeutic Area over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
- Abbott Laboratories Inc.
- Agilent Technologies Inc.
- Astrazeneca plc
- Bayer AG
- Charles River Laboratories International Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline PLC
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Shimadzu Corp
- Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Frequently Asked Questions about the Asian Pacific Drug Discovery Market 2020-2030
What is the estimated value of the Asian Pacific Drug Discovery Market 2020-2030?
What is the growth rate of the Asian Pacific Drug Discovery Market 2020-2030?
What is the forecasted size of the Asian Pacific Drug Discovery Market 2020-2030?
Who are the key companies in the Asian Pacific Drug Discovery Market 2020-2030?
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | November 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 12453.7 Million |
| Forecasted Market Value ( USD | $ 34231.2 Million |
| Compound Annual Growth Rate | 10.6% |
| Regions Covered | Asia Pacific |
Table of Contents
1 Introduction1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis
3 Segmentation of Asia Pacific Market by Drug Type
3.1 Market Overview by Drug Type
3.2 Small Molecule Drugs
3.3 Biologic Drugs
4 Segmentation of Asia Pacific Market by Service
4.1 Market Overview by Service
4.2 Medicinal Chemical Services
4.3 Biological Services
4.4 Drug Metabolism and Pharmacokinetics (DMPK) Services
4.5 Other Pharmaceutical Services
5 Segmentation of Asia Pacific Market by Process
5.1 Market Overview by Process
5.2 Target Selection
5.3 Target Validation
5.4 Hit-To-Lead Identification
5.5 Lead Optimization
5.6 Candidate Validation
6 Segmentation of Asia Pacific Market by Technology
6.1 Market Overview by Technology
6.2 High Throughput Screening
6.3 Combinatorial Chemistry
6.4 Pharmacogenomics and Pharmacogenetics
6.5 Nanotechnology
6.6 Bioanalytical Instruments
6.7 Biochips
6.8 Bioinformatics
6.9 Other Technologies
7 Segmentation of Asia Pacific Market by Therapeutic Area
7.1 Market Overview by Therapeutic Area
7.2 Oncology
7.3 Neurology
7.4 Infectious and Immune System Diseases
7.5 Digestive System Diseases
7.6 Cardiovascular Diseases
7.7 Diabetes
7.8 Respiratory Disease
7.9 Other Therapeutic Areas
8 Segmentation of Asia Pacific Market by End User
8.1 Market Overview by End User
8.2 Pharmaceutical Companies
8.3 Contract Research Organizations (CROs)
8.4 Research Institutes
8.5 Other End Users
9 Asia-Pacific Market 2019-2030 by Country
9.1 Overview of Asia-Pacific Market
9.2 Japan
9.3 China
9.4 Australia
9.5 India
9.6 South Korea
9.7 Rest of APAC Region
10 Competitive Landscape
10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
- Abbott Laboratories Inc.
- Agilent Technologies Inc.
- Astrazeneca plc
- Bayer AG
- Charles River Laboratories International Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline PLC
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Shimadzu Corp
- Thermo Fisher Scientific Inc.
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Total Number of Registered Clinical Studies Worldwide, 2010-2019
Table 6. Main Product Trends and Market Opportunities in Asia Pacific Drug Discovery Market
Table 7. Asia Pacific Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 8. Asia Pacific Drug Discovery Market by Service, 2019-2030, $ mn
Table 9. Asia Pacific Drug Discovery Market by Process, 2019-2030, $ mn
Table 10. Asia Pacific Drug Discovery Market by Technology, 2019-2030, $ mn
Table 11. Asia Pacific Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 12. Asia Pacific Drug Discovery Market by End User, 2019-2030, $ mn
Table 13. APAC Drug Discovery Market by Country, 2019-2030, $ mn
Table 14. Japan Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 15. Japan Drug Discovery Market by Service, 2019-2030, $ mn
Table 16. Japan Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 17. China Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 18. China Drug Discovery Market by Service, 2019-2030, $ mn
Table 19. China Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 20. Australia Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 21. Australia Drug Discovery Market by Service, 2019-2030, $ mn
Table 22. Australia Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 23. India Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 24. India Drug Discovery Market by Service, 2019-2030, $ mn
Table 25. India Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 26. South Korea Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 27. South Korea Drug Discovery Market by Service, 2019-2030, $ mn
Table 28. South Korea Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 29. Drug Discovery Market in Rest of APAC by Country/Region, 2019-2030, $ mn
Table 30. Abbott Laboratories Inc.: Company Snapshot
Table 31. Abbott Laboratories Inc.: Business Segmentation
Table 32. Abbott Laboratories Inc.: Product Portfolio
Table 33. Abbott Laboratories Inc.: Revenue, 2018-2020, $ mnList of Figures:Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 4. Asia Pacific Drug Discovery Market, 2019-2030, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Drug Discovery Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060
Figure 9. Primary Restraints and Impact Factors of Asia Pacific Drug Discovery Market
Figure 10. Investment Opportunity Analysis
Figure 11. Porter’s Five Forces Analysis of Asia Pacific Drug Discovery Market
Figure 12. Breakdown of Asia Pacific Drug Discovery Market by Drug Type, 2019-2030, % of Revenue
Figure 13. Asia Pacific Addressable Market Cap in 2021-2030 by Drug Type, Value ($ mn) and Share (%)
Figure 14. Asia Pacific Drug Discovery Market by Drug Type: Small Molecule Drugs, 2019-2030, $ mn
Figure 15. Asia Pacific Drug Discovery Market by Drug Type: Biologic Drugs, 2019-2030, $ mn
Figure 16. Breakdown of Asia Pacific Drug Discovery Market by Service, 2019-2030, % of Sales Revenue
Figure 17. Asia Pacific Addressable Market Cap in 2021-2030 by Service, Value ($ mn) and Share (%)
Figure 18. Asia Pacific Drug Discovery Market by Service: Medicinal Chemical Services, 2019-2030, $ mn
Figure 19. Asia Pacific Drug Discovery Market by Service: Biological Services, 2019-2030, $ mn
Figure 20. Asia Pacific Drug Discovery Market by Service: Drug Metabolism and Pharmacokinetics (DMPK) Services, 2019-2030, $ mn
Figure 21. Asia Pacific Drug Discovery Market by Service: Other Pharmaceutical Services, 2019-2030, $ mn
Figure 22. Breakdown of Asia Pacific Drug Discovery Market by Process, 2019-2030, % of Sales Revenue
Figure 23. Asia Pacific Addressable Market Cap in 2021-2030 by Process, Value ($ mn) and Share (%)
Figure 24. Asia Pacific Drug Discovery Market by Process: Target Selection, 2019-2030, $ mn
Figure 25. Asia Pacific Drug Discovery Market by Process: Target Validation, 2019-2030, $ mn
Figure 26. Asia Pacific Drug Discovery Market by Process: Hit-To-Lead Identification, 2019-2030, $ mn
Figure 27. Asia Pacific Drug Discovery Market by Process: Lead Optimization, 2019-2030, $ mn
Figure 28. Asia Pacific Drug Discovery Market by Process: Candidate Validation, 2019-2030, $ mn
Figure 29. Breakdown of Asia Pacific Drug Discovery Market by Technology, 2019-2030, % of Revenue
Figure 30. Asia Pacific Addressable Market Cap in 2021-2030 by Technology, Value ($ mn) and Share (%)
Figure 31. Asia Pacific Drug Discovery Market by Technology: High Throughput Screening, 2019-2030, $ mn
Figure 32. Asia Pacific Drug Discovery Market by Technology: Combinatorial Chemistry, 2019-2030, $ mn
Figure 33. Asia Pacific Drug Discovery Market by Technology: Pharmacogenomics and Pharmacogenetics, 2019-2030, $ mn
Figure 34. Asia Pacific Drug Discovery Market by Technology: Nanotechnology, 2019-2030, $ mn
Figure 35. Asia Pacific Drug Discovery Market by Technology: Bioanalytical Instruments, 2019-2030, $ mn
Figure 36. Asia Pacific Drug Discovery Market by Technology: Biochips, 2019-2030, $ mn
Figure 37. Asia Pacific Drug Discovery Market by Technology: Bioinformatics, 2019-2030, $ mn
Figure 38. Asia Pacific Drug Discovery Market by Technology: Other Technologies, 2019-2030, $ mn
Figure 39. Breakdown of Asia Pacific Drug Discovery Market by Therapeutic Area, 2019-2030, % of Revenue
Figure 40. Asia Pacific Addressable Market Cap in 2021-2030 by Therapeutic Area, Value ($ mn) and Share (%)
Figure 41. Asia Pacific Drug Discovery Market by Therapeutic Area: Oncology, 2019-2030, $ mn
Figure 42. Asia Pacific Drug Discovery Market by Therapeutic Area: Neurology, 2019-2030, $ mn
Figure 43. Asia Pacific Drug Discovery Market by Therapeutic Area: Infectious and Immune System Diseases, 2019-2030, $ mn
Figure 44. Asia Pacific Drug Discovery Market by Therapeutic Area: Digestive System Diseases, 2019-2030, $ mn
Figure 45. Asia Pacific Drug Discovery Market by Therapeutic Area: Cardiovascular Diseases, 2019-2030, $ mn
Figure 46. Asia Pacific Drug Discovery Market by Therapeutic Area: Diabetes, 2019-2030, $ mn
Figure 47. Asia Pacific Drug Discovery Market by Therapeutic Area: Respiratory Disease, 2019-2030, $ mn
Figure 48. Asia Pacific Drug Discovery Market by Therapeutic Area: Other Therapeutic Areas, 2019-2030, $ mn
Figure 49. Breakdown of Asia Pacific Drug Discovery Market by End User, 2019-2030, % of Revenue
Figure 50. Asia Pacific Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%)
Figure 51. Asia Pacific Drug Discovery Market by End User: Pharmaceutical Companies, 2019-2030, $ mn
Figure 52. Asia Pacific Drug Discovery Market by End User: Contract Research Organizations (CROs), 2019-2030, $ mn
Figure 53. Asia Pacific Drug Discovery Market by End User: Research Institutes, 2019-2030, $ mn
Figure 54. Asia Pacific Drug Discovery Market by End User: Other End Users, 2019-2030, $ mn
Figure 55. Breakdown of APAC Drug Discovery Market by Country, 2019 and 2030, % of Revenue
Figure 56. Contribution to APAC 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 57. Drug Discovery Market in Japan, 2019-2030, $ mn
Figure 58. Drug Discovery Market in China, 2019-2030, $ mn
Figure 59. Drug Discovery Market in Australia, 2019-2030, $ mn
Figure 60. Drug Discovery Market in India, 2019-2030, $ mn
Figure 61. Drug Discovery Market in South Korea, 2019-2030, $ mn
Figure 62. Drug Discovery Market in Rest of APAC, 2019-2030, $ mn
Figure 63. Growth Stage of Asia Pacific Drug Discovery Industry over the Forecast Period
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories Inc.
- Agilent Technologies Inc.
- Astrazeneca plc
- Bayer AG
- Charles River Laboratories International Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline PLC
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Shimadzu Corp
- Thermo Fisher Scientific Inc.
Methodology
LOADING...
